EUROGIN.COM
Welcome
Committee
Preliminary Prog
Overview
HPVI
STIs
S. Femmes
Symposia
Ed. material
Registration
Abstract submission
Proceeding
CME
Tech. info
Guideline
Grants
General Info
Partners
Sponsoring
Accomodation
Social programme
Contact
Sign up for our email mailing
list to receive updates
about Eurogin 2003.
Your email address:


SCIENTIFIC PROGRAMME

Sunday 13 April I Monday 14 April I Tuesday 15 April I Wednesday 16 April I

Sunday 13 April 2003

Training Courses

For clinicians, pre-congress courses aim to provide educational strategies, enablig acquisition of skills and an update of expertise in line with the aims of Continuing Medical Education. This should allow participants to integrate into their clinical practice, the terminology, basic and advanced principles of instrumentation, normal and abnormal colposcopic patterns as well as diagnosis and management of cervical and vulvar diseases.
For pathologists and virologists, the course comprises a comprehensive introduction to cervical cytopathology, terminology, laboratory quality standards, normal and abnormal patterns of cervical cytology with both conventional smears and liquid based cytology. Case studies of cyto-histological correlations and HPV-testing applications will be presented. Enrolment in these sessions is limited in order to facilitate optimal interaction between faculty and attendees ; kindly pre-register to attend these sessions
Registration on line

TC1 COMPREHENSIVE COLPOSCOPY COURSE

TC1-1 DIAGNOSIS OF CIN

 

Chairs : S. Dexeus (Spain), B. Blanc (France), A. Singer (UK)

• Educational lecture H. Jones (USA)
• Colposcopy of the normal cervix A. Singer (UK)
• Grading colposcopic features S. Dexeus (Spain)
• Colposcopy of the abnormal cervix (CIN and HPV infections) P. Walker (UK)
• Colposcopy of glandular lesions J. Jordan (UK)
• Discussion

TC1-2 TREATMENT OF CIN
  Chairs : G. de Palo (Italy), J.C. Boulanger (France)

• How to treat? W. Prendiville (Ireland)
• Results - Complications- Follow-up D. Luesley (UK)
TC1-3 INTERACTIVE COURSE: VIDEO MASTER CLASS AND CASE STUDIES (TOUCH PAD)
  Chairs : M. Roy (Canada), J.L. Leroy (France), A. Singer (UK)
With the contribution of the experts:
A. Singer (UK), J.L. Leroy (France), D. Luesley (UK), A. Ferenczy (Canada),
F. Boselli (Italie), A. Perino (Italie), J.C. Boulanger (France), J.L. Mergui (France),
T.J.M. Helmerhost (), D. Pereira da Silva (Portugal), J.A. Moutinho (Portugal),
M. Menton (Germany), E. Diakomanolis (Greece), S.A. Tatti (Argentina),
P. Naud (Brazil), S. Dexeus (Spain), A. Bar-Am (Israel), J. Jordan (UK),
R. Testa (Argentina), P. Walker (UK), G. De Palo (Italy), M. Peroni (Italy),
H. Jones (USA), B. Blanc (France)

TC2 CYTOPATHOLOGY COURSE

 

Chairs : E. Mc Googan (UK), M. Austin (USA), M. Sherman (USA), A. Verhest (Belgium)
• Educational lecture E. Wilkinson (USA)
• Basic issues and terminology M. Sherman (USA)
• Liquid-based cytology M. Austin (USA)
• Computer-assisted automation D. Wilbur (France)
• Proliferation and differentiation markers E. Mc Googan (UK)
• Molecular techniques for cytodiagnosis J. Linder (USA)

INTERACTIVE CASE STUDIES

With the contribution of the experts:
R. Ashfaq (USA), R. Dachez (France), S. Labbe (France), N. Froment (France),
R. Marty (France), L. Zerat (France), J. Linder (USA), F. Montz (USA),
O. Real (Portugal), A. Meisels (Canada), J.C. Hammou (France),
H. Koutsellini (Greece), J. Linder (USA), D. Wilbur (USA).

TC3 VULVAR DISEASES COURSES
TC3-1 VULVAR PATHOLOGY COURSE

 

Chairs: M. Faure (France), M. Roy (Canada), M. Sideri (Italy)

• Educational lecture R. W. Jones (New Zealand)
• The vulva: from normal to disease M. Moyal-Barracco (France)
• Lichen sclerosus and vulvar hyperplasia S. Neill (UK)
• Lichen erosive of the vulva M. Pelisse (France)
• Ulceration of the vulva M. Faure (France)
• VIN, diagnosis and treatment M. Sideri (Italy)
• Paget’s disease B. Paniel (France)
• Vulvodynia J. Bornstein (Israel)
• Psychosomatic evaluation of vulvar pain M. Steben (Canada)

INTERACTIVE CASE STUDIES (TOUCH PAD)

 

Chairs: M. Roy (Canada), L. Micheletti (Italy), M. Pelisse (France)

With the contribution of the experts:
Van Beurden (The Netherlands), M. Faure (France), M. Pelisse (France),
L. Micheletti (Italy), J. Bornstein (Israel), R. W. Jones (New Zealand),
M. Sideri (Italy), M. Friedman (Israel), M. Moyal-Barracco (France).
   

TC4 OFFICE GYNAECOLOGICAL PROCEDURES

TC4-1 LOWER GENITAL TRACT

 

Chairs : A. Ferenczy (Canada), L. Pardal (Portugal)

• Digital colposcopy Q.S. Chong (Indonesia)
• EEC biopsy versus endocervical brusching A. Ferenczy (Canada)
• Indications and modalities of CO2 laser A. Singer (UK)
• LLETZ, SWETZ W. Prendiville (Ireland)
• Variloop A. Mergui (France)
• Cryotherapy A. Ferenczy (Canada)
• Treatment of vaginal disease E. Paraskevaidis (Greece)

TC4-2 BREAST
  Ductal lavage and the management of women at high risk of breast cancer V. Vogel (USA)
TC1-3 ENDOMETRIUM
  Chairs : W. Prendiville (Ireland), E. Paraskevaidis (Greece)

• Hysterosonography versus hysteroscopy N. Perrot (France)
• 3D ultrasound versus 2D vaginal scanning for uterine diseases F. Bonnilla-Musoles (Spain)
• Adnexal diseases: the suspicious signs J.N. Buy (France)
• Management of post-menopausal bleeding L. Boubli (France)
• Hysteroscopic treatment of synechias L. Montevecchi (Italy)
• Office hysteroscopy: is it possible during consultation? J.L. Mergui (France)
 

SEMINARS
  The purpose of these seminars is to provide recommendations for improved clinical practice based on collective expertise. Appointed experts will be at work and their conclusions will be presented during a plenary session.The written conclusions will be available during the congress. Observers are welcome at these sessions on the strict proviso that advance registration is made by completing and returning Form D. These sessions are open to everyone involved in organising cervical cancer screening programmes.
The aims are :
• to initiate dialogue and to provide the opportunity for exchanging experiences
• to assess the medical and economic advantages of the programmes
• to discuss the feasibility of rational approaches to optimising both cytological management of the disease and quality assurance, taking into consideration the role of recent technology and economic necessities.
Registration on line
SEM1 HPV IN CLINICAL PRACTICE

SEM1-1 ROLE OF HPV TESTING FOR MANAGING PATIENTS WITH ABNORMAL PAP

 

Chairs : T. Cox (USA), C. Meijer (The Netherlands)
• Epidemiological evidence and rationale for HPV testing E. Franco (Canada)
• Novel markers for risk stratification of HPV positive women A. Lorincz (USA)
• Revue of current practice W. Kinney (USA)
• Management as a result of ALTS trial and Bethesda protocols T. Cox (USA)
• HPV as a test of cure T. Wright (USA)
• Discussion

HPV TESTING IN PRIMARY SCREENING, AN INTERNATIONAL EXPERIENCE
SEM1-2 Developed countries

  Chairs : T. Cox (USA), C. Meijer (The Netherlands)
• United Kingdom: the HART study update J. Cuzick (UK)
• France C. Clavel (France)
• Germany T. Iftner (Germany)
• Netherlands C. Meijer (NL)
• Canada S. Ratnam (Canada)
• Portland study update A. Lorincz (USA)
• Discussion
SEM1-3 Developing countries
  Chairs : T. Cox (USA), C. Meijer (The Netherlands)
• South Africa L. Denny (South Africa)
• India R. Sankaranarayanan (France)
• China J.L. Belinson (USA)
• Conclusions T. Cox (USA), C. Meijer (The Netherlands)

SEM2 EMERGING ISSUES IN CERVICAL CANCER SCREENING

SEM2-1 Developed countries
  Chairs: F. Montz (USA), M. Parkin (France), J. Patnick (UK)
• Epidemiology of cervix cancer in developed countries. Evolution since the introduction of the PAP test M. Parkin (France)
• Screening programs for cervical cancer M. Shier (Canada), J. Patnick (UK), H. Mitchell (Australia)
• Challenge for the future F. Montz (USA)
• Economics: efficacy, cost-effectiveness and limiting factors D. Habbema (Netherlands)
• General Discussion
SEM2-2 Developing countries
  Chairs: R. Sankaranarayanan (F), L. Denny (South Africa), H. Mitchell (Australia)
• Cytology L. Denny (South Africa)
• HPV testing T. Wright (USA)
• VIA R. Sankaranarayanan (F)
• Real time screening methods A. Singer (UK)
• Screening methods relevant to developing countries T. Wright (USA)
Discussion
   



Congress Secretariat
VBCE – EUROGIN – C. Cabotin
33, rue de l’Abbé Groult, 75015 Paris - France
Tel. +33 (0)1 45 33 60 46
Fax +33 (0)1 45 33 57 15
Scientific Secretariat
EUROGIN
174, rue de Courcelles, 75017 Paris -France
Tel. +33 (0)1 44 40 01 20
Fax +33 (0)1 47 66 74 70
admin@eurogin.com